Proportions of patients without detectable hepatitis C virus RNA in serum
| Interferon-α group (n = 15) | Interferon-β group (n = 12) | p Value (χ2 test) | |
|---|---|---|---|
| Week 4 | 4 (27%) | 3 (25%) | 0.92 |
| Week 12 | 7 (47%) | 10 (83%) | 0.049 |
| Week 24 (end of therapy) | 10 (67%) | 9 (75%) | 0.64 |
| Week 48 | 0 (0%) | 3 (25%) | 0.040 |